chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed red, facial flush and sweated 15 minutes after 1st dose. Resolved same evening. Developed small number of hive-like sores (2-days later) on anterior neck, upper abdomen and one on the back. One sore still remains on front of his neck as of 5/22/2021.
Patient at 16:40pm felt lightheaded, weak, and knees buckled after her vaccine was given as she was walking to the monitoring area. She dropped to a sitting position on teh floor without any injuries. RRT called, vitals stable, BP 110/72, 105/78, 112/76, pulse 79, O2Sat 96%, temp 98.3. Pt was given 500cc water to drink with good result. She had not eaten breakfast. Patient monitored until 5pm, esocrted to uber and at 4:42pm called NP to say she arrived safely.
Patient received his 5th Anthrax vaccine am of 17AUG07 when 15 minutes later he felt nauseated, then vomited once. He felt a bit better but still a little queasy. Without treatment, he finally felt well after one hour.
he developed bright red rash from shoulder bone to her elbow; injection site is still red; experiencing lot of pain on upper arm left; This spontaneous case was reported by an occupational therapist (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (he developed bright red rash from shoulder bone to her elbow), VACCINATION SITE ERYTHEMA (injection site is still red) and VACCINATION SITE PAIN (experiencing lot of pain on upper arm left) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE RASH (he developed bright red rash from shoulder bone to her elbow), VACCINATION SITE ERYTHEMA (injection site is still red) and VACCINATION SITE PAIN (experiencing lot of pain on upper arm left). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (he developed bright red rash from shoulder bone to her elbow), VACCINATION SITE ERYTHEMA (injection site is still red) and VACCINATION SITE PAIN (experiencing lot of pain on upper arm left) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Localized erythema on L shoulder at injection site 8cm round-non tender, No discharge. No fever.
BLISTERS NEAR INJECTION SITE; 2 CLUSTERS 1 CM FROM SITE, ONE CLUSTER 8 CM ANTERIOR TO THAT; CLUSTERS ABOUT 1 CM X 0.5 CM SIZE.  ARM A LITTLE SORE, BUT NOTHING OUT OF THE ORDINARY FOLLOWING VACCINATION.  GIRLFRIEND FIRST NOTICED BLISTERS AT 10 PM 9/15/16, BUT THEY MIGHT HAVE APPEARED EARLIER WITHOUT MY NOTICING.  NO ITCHING.  FRIDAY 9/16/2016 AT 3 PM, APPEARANCE UNCHANGED.
Felt chills; feverish; tired; had body aches for 24 hrs after 2nd dose of vaccine.; This is a spontaneous report from a non-contactable physician. A 54-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on Jan2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 on an unspecified date as dose 1, single for covid-19 immunisation. The patient experienced felt chills, feverish, tired, and had body aches for 24 hrs after 2nd dose of vaccine on an unspecified date of 2021. Patient did not receive treatment for events. Patient did not have covid prior vaccination and covid was not tested post vaccination. The outcome of all events was recovered on an unspecified date of 2021.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Patient reported mild rash that started at injection sight and spread across body on 2/11/2021. Patient was seen in clinic by one our doctors and given steroids. Patient's rash did improve and was able to present for second injection.
Had vaccine in right arm (deltoid) yesterday and woke this AM with hand and lower arm tingling and occasional sharp pain in hand. Full ROM and intact sensation.
Patient reaction signs: - Pale skin - Loss of vision - Dizziness - Headache - Diluted eyes (per guardian)  - "Feeling like passing out" (per patient)   Nurse triage was needed to this interaction.    MAP was 64 Glucose was 110   Signs after 20 minutes: - Headache - Coloration returned - Patients states standing up might cause dizziness and feeling of passing out. - Vision returned   MAP was 69   PCP came in to room and discussed situation. PCP clarified not being vaccine reaction but vasovagal reaction. Patient verbalized understanding.    Patient was released from clinic with no abnormal signs at 2:55 PM.
My experience with COVID has been a fever for two days. I've had a mild sore throat with congestion. I lost my taste and smell for forty-eight hours. My congestion was the worse symptom.
Patient has upper arm swelling and bruising which spread from upper arm to forearm. Patient was instructed by ER staff (by telephone) to ice the area and take Benadryl. Symptoms better at time of reporting to pharmacy.
Hospitalized with AKI with creatinine of 3.61 she was exposed to COVID on 1/2 and developed symptoms on 1/7 tested positive 1/11. AKI probably due to Vancomycin she was taking for BSI.
Information has been received from a mother concerning her 18 year old daughter with no pertinent medical history or drug reactions/allergies who on 22-MAY-2007 was vaccinated with a first dose of Gardasil (lot# unknown) 0.5 ml IM.  There was no concomitant medication.  On 26-JUL-2007 the patient was vaccinated with a second dose of Gardasil (658094/0524U).  In the same day the patient developed a large number of canker sores all over in her mouth.  Medical attention was sought.  The patient did not have any adverse events after the first dose.  At the time of reporting the patient was still recovering.  Follow up information was received from a physician.  As of 15-AUG-2007 the patient had two sores left in her mouth.  No further information was provided regarding this adverse experience.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 9/17/2007. Additional information is not expected.
Covid onset of symptoms on May 14, 2022.  Diagnosis of Covid on May 18, 2022.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 67-year-old female patient who received SHINGRIX. Concomitant products included Levothyroxine, Simvastatin, citalopram and Lisinopril. On 25th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In April 2018, less than a week after receiving SHINGRIX, the patient experienced injection site erythema. On 25th April 2018, the patient experienced injection site swelling. On an unknown date, the outcome of the injection site swelling and injection site erythema were unchanged. The reporter considered the injection site swelling and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the right deltoid. The reporter stated that the patient had 2.5 to 3 inch enlarged circle with swelling and redness at injection site. Less than a week after receiving SHINGRIX, the patient experienced injection site erythema. All questions were asked. According to the pharmacist, the patient would follow up if any changes occurred in condition.
I had cob webs across my left eye, which turned out to be an occipital stroke; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot E19264), via an unspecified route of administration, administered in left arm on 15Mar2021 as single dose for COVID-19 immunisation. Medical history included diabetes, arthritis, high blood pressure (BP), and known allergies to adhesive. The patient was not pregnant. Concomitant medications included tolterodine l-tartrate (DETROL), propranolol hydrochloride (INDERAL), metformin, celecoxib (CELEBREX), and valsartan (DIOVAN). On 28Mar2021, the patient experienced cob webs across her left eye, which turned out to be an occipital stroke. She reported that she had good control of her BP so the cause of it was unknown at this time. Therapy of the event included Paxil and underwent doppler test and MRI. The event resulted in doctor or other healthcare professional office/clinic visit, and disability or permanent damage. The patient had no Covid prior vaccination and was not Covid tested post vaccination. Outcome of event was recovered with sequel in Mar2021.
On 4/30/21 she developed a red rash on her left arm that is getting larger in size and has hives on the inside of the elbow.  She has raised red rash all over her right arm.  There is also a rash on the inside of both legs all of the way down to her feet and a slight rash around her scalp line.  She has been using Benadryl on her left arm and has contacted her PCP for medical advice.
Local, redness and swelling at injection approximately 3 inches across, slightly indurated, hot and itchy. Beginning 24 hours post vaccination, lymph pain and swelling to L axilla. Pain in axilla, shoulder/pec area. This report is being completed 48 hours post vaccination. At about 36 hours post vaccination, patient reports sharp chest pain localized to left side of chest lasting approximately 15 minutes.
Fainted & hit & neck, abrasions to neck, paramedics assessed. Refused further medical care.
mom states child started screaming @ home, cont, when moving leg w/vax;pt got worst child cried when moves rt leg & rt thigh;
Acute gallstone pancreatitis  3/14/2021 1AM. Underwent cholecystectomy (laparoscopic) 3/15/2021
hot at the site of injection; itching at the site of injection; swollen arm at the site of injection which is size of golf ball; little sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot at the site of injection), VACCINATION SITE PRURITUS (itching at the site of injection), VACCINATION SITE PAIN (little sore at the injection site) and VACCINATION SITE SWELLING (swollen arm at the site of injection which is size of golf ball) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PAIN (little sore at the injection site). On 22-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot at the site of injection), VACCINATION SITE PRURITUS (itching at the site of injection) and VACCINATION SITE SWELLING (swollen arm at the site of injection which is size of golf ball). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site pain, Vaccination site swelling, Vaccination site pruritus and Vaccination site warmth, at an unspecified dose and frequency. On 21-Feb-2021, VACCINATION SITE PAIN (little sore at the injection site) had resolved. On 26-Feb-2021, VACCINATION SITE SWELLING (swollen arm at the site of injection which is size of golf ball) had resolved. At the time of the report, VACCINATION SITE WARMTH (hot at the site of injection) and VACCINATION SITE PRURITUS (itching at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Full body rash, large hives on torso, legs, buttocks, and arms. Nothing notable at injection site. Rash comes on at night, itchy and burning. Taking Benadryl, but no sure it helps. I'm trying to avoid food and drinks with high histamine. Day time, it goes away.  It started two days after injection and has been ongoing since (today will be day 5 of rash if it happens again this evening.)
Patient received the moderna vaccine on 4/10/21, 5/8/21 and 12/9/21. Presented to ER on 7/1/22 and found to be COVID positive. Patient is a gentleman who presented to the emergency department with complaints of acute on chronic generalized weakness.  Was found positive for COVID and was felt the weakness was secondary to that issue.  Was admitted and appropriately isolated and monitored for hypoxia.  Did not have any issues related to symptomatic COVID other than the weakness.  PT and OT were consulted.  Restarted on home medications but they were choir to adjustments in regards to hypoglycemia in the morning and also uncontrolled hypertension.  For details of med changes see below.  He continues very weak and was felt would benefit from continued rehab in a skilled, rehab type setting.  Nursing home placement was the best fit in terms of patient's endurance and physical therapy and occupational therapy requirements.  He was discharged to swing bed on 7/15/22
Wrong vaccine was given. Pt was suppose to receive a Menactra and was given a MenB. No side effects were noted.
Approx 1 wk p/receiving the MMR pt devel sore throat, swollen/tender lymph nodes in neck, fever, lethargy, nausea, h/a; sx have not resolved;
flu-like symptoms, I thought I had a touch of the flu.; A week later I started having severe pains in my calves, hips, shoulder, neck and back.; body aches, I never had a fever, but I was so achy, I couldn't believe how intense the pain was.; slight headache that day but it was gone the next day; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms, I thought I had a touch of the flu.), HEADACHE (slight headache that day but it was gone the next day), ARTHRALGIA (A week later I started having severe pains in my calves, hips, shoulder, neck and back.) and MYALGIA (body aches, I never had a fever, but I was so achy, I couldn't believe how intense the pain was.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced HEADACHE (slight headache that day but it was gone the next day). On 06-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms, I thought I had a touch of the flu.), ARTHRALGIA (A week later I started having severe pains in my calves, hips, shoulder, neck and back.) and MYALGIA (body aches, I never had a fever, but I was so achy, I couldn't believe how intense the pain was.). On 28-Feb-2021, HEADACHE (slight headache that day but it was gone the next day) had resolved. On 13-Apr-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms, I thought I had a touch of the flu.), ARTHRALGIA (A week later I started having severe pains in my calves, hips, shoulder, neck and back.) and MYALGIA (body aches, I never had a fever, but I was so achy, I couldn't believe how intense the pain was.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication details were provided.   This case was linked to MOD-2021-085486 (Patient Link).
I was sitting at rest in the am and I suddenly felt my heart begin to race. I called to my husband and we checked my pulse and it was up to 224 beats/minute.   I was able to get up and then rest for awhile, but my heart  began beating excessively fast again a few minutes later. The only change to my body was having the Pfizer- vaccine.
This spontaneous report as received from a physician refers to a 6 month old patient with prophylaxis. On 28-AUG-2017 the patient was vaccinated with PNEUMOVAX23 lot # M040004 for prophylaxis. Other suspect therapies included PREVNAR 13. On 28-AUG-2017 the patient experienced no adverse event. On an unknown date the patient experienced wrong drug administered. The outcome of wrong drug administered and no adverse event is unknown. The reporter considered wrong drug administered and no adverse event to be not related to PNEUMOVAX23. Additional information has been requested.
The day off there was alot of pain similar to a bruise, nauseous throughout day of and night, swelling in right hand,
From the site of the vaccine there is tingling and numbness randomly shooting down the arm; From the site of the vaccine there is tingling and numbness randomly shooting down the arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0170) via an unspecified route of administration in the right arm on 16Apr2021 at 09:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient previously received hydrocodone bitartrate; paracetamol (VICODIN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included etonogestrel (NEXPLANON); taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the right arm on 26Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 08:00, from the site of the vaccine, the patient experienced tingling and numbness randomly shooting down her arm for the last 2 weeks (at the time of this report) and it seemed to be more frequent as time goes on. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events from the site of the vaccine there is tingling and numbness randomly shooting down the arm were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
couple patients skipped getting their 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in an unknown number of patients who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date, over a year/ two years ).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist reported that a couple patients skipped getting their 2nd dose of Shingrix due COVID and its over a year/ two years now. The reporter consented to follow up. The reporter asked for additional details but pharmacist could not provide (seemed in a rush).
Patient states having pain/soreness and tenderness in same arm as injection site. Also pain is radiating to shoulder blade making it difficult for her to move her arm.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 19-MAR-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number R021055 with expiration date in 01-APR-2020) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001848: US-009507513-1907USA001849: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000989: US-009507513-1907USA000962: US-009507513-1907USA000988: US-009507513-1907USA000963: US-009507513-1907USA000953: US-009507513-1907USA000959: US-009507513-1907USA000968: US-009507513-1907USA000967: US-009507513-1907USA000964: US-009507513-1907USA000966: US-009507513-1907USA000954: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000965:
Information has been received from a physician's assistant (PA), concerning a 14 year old female patient, who on 12-FEB-2008 was vaccinated IM with the second dose, 0.5 ml, of Gardasil (lot # not reported).  Concomitant therapy included diphenhydramine HC1 (BENADRYL).  On 02-FEB-2008, following the vaccination, the patient developed syncope and a seizure.  She was rushed to the emergency room, and was released the same day.  At the time of this report, the patient had recovered (duration and date not specified).  The PA commented she "felt that the vaccine was administered incorrectly by one of the staff."  The PA considered syncope and seizure to be serious as an other important medical event.  Additional information has been requested.